| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.24 | 3e-07 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.24 | 8e-06 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.22 | 7e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.19 | 7e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0005 |